AdvanDx Secures $2,500,000 New Funding Round

  • Feed Type
  • Date
    3/18/2015
  • Company Name
    AdvanDx
  • Mailing Address
    400 TradeCenter Woburn, MA 01801 USA
  • Company Description
    AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available in hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.
  • Website
    http://www.advandx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor